Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pre-frontal parvalbumin interneurons in schizophrenia: a meta-analysis of post-mortem studies
Stephen Kaar, Ilinca Angelescu, Tiago Reis Marques, et al.
Journal of Neural Transmission (2019) Vol. 126, Iss. 12, pp. 1637-1651
Open Access | Times Cited: 113

Showing 26-50 of 113 citing articles:

The Balance in the Head: How Developmental Factors Explain Relationships Between Brain Asymmetries and Mental Diseases
Martina Manns, Georg Juckel, Nadja Freund
Brain Sciences (2025) Vol. 15, Iss. 2, pp. 169-169
Open Access
KEAP1‐NRF2/HO‐1 Pathway Promotes Ferroptosis and Neuronal Injury in Schizophrenia
Feng Zhu, Dan Tang, Sherwin E. Hua
Brain and Behavior (2025) Vol. 15, Iss. 3
Open Access
Gamma Oscillations and Potassium Channel Modulation in Schizophrenia: Targeting GABAergic Dysfunction
Stephen Kaar, Judith Nottage, Ilinca Angelescu, et al.
Clinical EEG and Neuroscience (2023) Vol. 55, Iss. 2, pp. 203-213
Open Access | Times Cited: 12
Pharmacogenetic activation of parvalbumin interneurons in the prefrontal cortex rescues cognitive deficits induced by adolescent MK801 administration
Linda A. Chamberlin, Sha-Sha Yang, Erin McEachern, et al.
Neuropsychopharmacology (2023) Vol. 48, Iss. 9, pp. 1267-1276
Closed Access | Times Cited: 11
D-serine reconstitutes synaptic and intrinsic inhibitory control of pyramidal neurons in a neurodevelopmental mouse model for schizophrenia
Xiaoqin Zhang, Le Xu, Xinyi Zhu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 11
Fine structure analysis of perineuronal nets in the ketamine model of schizophrenia
Rahul Kaushik, Nikita Lipachev, Gabriela Matuszko, et al.
European Journal of Neuroscience (2020) Vol. 53, Iss. 12, pp. 3988-4004
Open Access | Times Cited: 31
Implications of Extended Inhibitory Neuron Development
Jae-Yeon Kim, Mercedes F. Paredes
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5113-5113
Open Access | Times Cited: 26
Structural and biochemical alterations in dendritic spines as key mechanisms for severe mental illnesses
Sebastian Reyes-Lizaola, Ulises Luna-Zarate, Hiram Tendilla‐Beltrán, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2023) Vol. 129, pp. 110876-110876
Closed Access | Times Cited: 9
Exploratory Analysis of MicroRNA Alterations in a Neurodevelopmental Mouse Model for Autism Spectrum Disorder and Schizophrenia
Susana García-Cerro, Ana Gómez-Garrido, Gonçalo Garcia, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2786-2786
Open Access | Times Cited: 3
Prefrontal oscillatory slowing in early-course schizophrenia is associated with worse cognitive performance and negative symptoms: a TMS-EEG study
Francesco Donati, Ahmad Mayeli, Bruno Andry Nascimento Couto, et al.
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2024)
Closed Access | Times Cited: 3
Adult conditional knockout of PGC-1α in GABAergic neurons causes exaggerated startle reactivity, impaired short-term habituation and hyperactivity
Jia Wang, Huang-Rong Song, Meina Guo, et al.
Brain Research Bulletin (2020) Vol. 157, pp. 128-139
Closed Access | Times Cited: 24
Are CB2 Receptors a New Target for Schizophrenia Treatment?
Isadora Lopes Cortez, Naielly Rodrigues da Silva, Francisco Silveira Guimarães, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 24
Ketamine Alters Functional Gamma and Theta Resting-State Connectivity in Healthy Humans: Implications for Schizophrenia Treatment Targeting the Glutamate System
Stjepan Ćurić, Christina Andreou, Guido Nolte, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 22
Microglia and Sensitive Periods in Brain Development
Julia E. Dziabis, Staci D. Bilbo
Current topics in behavioral neurosciences (2021), pp. 55-78
Closed Access | Times Cited: 22
The Neurometabolic Basis of Mood Instability: The Parvalbumin Interneuron Link—A Systematic Review and Meta-Analysis
Antonello Pinna, Alessandro Colasanti
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 20
Congenital Hypothyroidism and Brain Development: Association With Other Psychiatric Disorders
Katsuya Uchida, Mao Suzuki
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 20
Natural Oscillatory Frequency Slowing in the Premotor Cortex of Early-Course Schizophrenia Patients: A TMS-EEG Study
Francesco Donati, Ahmad Mayeli, Kamakashi Sharma, et al.
Brain Sciences (2023) Vol. 13, Iss. 4, pp. 534-534
Open Access | Times Cited: 8
Activation of prefrontal parvalbumin interneurons ameliorates working memory deficit even under clinically comparable antipsychotic treatment in a mouse model of schizophrenia
Yosefu Arime, Yoshito Saitoh, Mikiko Ishikawa, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 4, pp. 720-730
Open Access | Times Cited: 7
GABAergic and inflammatory changes in the frontal cortex following neonatal PCP plus isolation rearing, as a dual-hit neurodevelopmental model for schizophrenia
Jennifer Cale, Ethan J. Chauhan, Joshua J. Cleaver, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 9, pp. 6968-6983
Open Access | Times Cited: 2
Perineuronal Net Microscopy: From Brain Pathology to Artificial Intelligence
Mikhail Paveliev, Anton Egorchev, Foat Musin, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4227-4227
Open Access | Times Cited: 2
Bipolar disorders and schizophrenia: discrete disorders?
Micaela Dines, Mariana Kes, Delfina Ailán, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
Cannabidiol as an antipsychotic drug
Débora Cristina Niero Fabris, João Roberto Lisboa, Francisco Silveira Guimarães, et al.
International review of neurobiology (2024), pp. 295-317
Open Access | Times Cited: 2
Subclass imbalance of parvalbumin-expressing GABAergic neurons in the hippocampus of a mouse ketamine model for schizophrenia, with reference to perineuronal nets
Risako Fujikawa, Jun Yamada, Shozo Jinno
Schizophrenia Research (2020) Vol. 229, pp. 80-93
Closed Access | Times Cited: 18
Ketamine as a pharmacological tool for the preclinical study of memory deficit in schizophrenia
José Eduardo Suárez Santiago, Gabriel Roldán, Ofir Picazo
Behavioural Pharmacology (2022) Vol. 34, Iss. 2-3, pp. 80-91
Closed Access | Times Cited: 12
Involvement of an Aberrant Vascular System in Neurodevelopmental, Neuropsychiatric, and Neuro-Degenerative Diseases
Keiichi Ishihara, Kazuyuki Takata, Ken‐ichi Mizutani
Life (2023) Vol. 13, Iss. 1, pp. 221-221
Open Access | Times Cited: 6

Scroll to top